Jason Kelly is the CEO of Ginkgo Bioworks. Kelly is based in USA. Kelly has held the role since 2008.
Jason Kelly co-founded Ginkgo Bioworks in 2008 and has served as CEO since inception. He holds a Ph.D. in Biological Engineering and a B.S. in Chemical Engineering and Biology from MIT, and previously chaired the U.S. National Security Commission on Emerging Biotechnology.
Recent developments
AI summary of recent coverageRecent coverage of Jason Kelly has focused on Ginkgo Bioworks' advancement in autonomous laboratory technology, including a major $47 million robot-driven facility project and Kelly's public statements positioning the company's automation capabilities as a transformative moment for biotechnology. Coverage has also touched on Kelly's stock transactions and the company's strategic shift toward commercializing lab robotics following previous financial challenges, alongside broader discussions of competitive dynamics between Western and Chinese biotech sectors.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Jason Kelly, it will appear here — and tie into the news timeline.
Jason Kelly: FAQ
- Who is Jason Kelly?
- Jason Kelly is the Co-founder & CEO of Ginkgo Bioworks, based in USA.
- What company does Jason Kelly lead?
- Jason Kelly is CEO of Ginkgo Bioworks, a role held since 2008.